Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
2022 · Cell Reports · 72 citations
https://doi.org/10.1016/j.celrep.2022.111162
J
Jemma Castle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
150
Citations
5
h-index
4
i10-index
Jemma Castle is an academic researcher from Newcastle University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Epigenetics and DNA Methylation & Mitochondrial Function and Pathology. The author has an h-index of 5, co-authored 17 publications.
Papers by this author
worksMolecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
2023 · Acta Neuropathologica · 12 citations
https://doi.org/10.1007/s00401-023-02566-0
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing
2025 · Acta Neuropathologica Communications · 1 citations
https://doi.org/10.1186/s40478-025-02049-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat